Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Carcinoma, Non-Small-Cell Lung 767Lung Neoplasms 340Ovarian Neoplasms 318Breast Neoplasms 277Fallopian Tube Neoplasms 158Triple Negative Breast Neoplasms 144Small Cell Lung Carcinoma 142Neoplasms 134Squamous Cell Carcinoma of Head and Neck 122Carcinoma, Ovarian Epithelial 114Neoplasm Metastasis 85Head and Neck Neoplasms 80Endometrial Neoplasms 77Esophageal Neoplasms 71Uterine Cervical Neoplasms 70Adenocarcinoma of Lung 69Neuroblastoma 55Central Nervous System Neoplasms 52Carcinoma 50Lymphoma, Large B-Cell, Diffuse 49Brain Neoplasms 48Recurrence 47Prostatic Neoplasms 44Parkinson Disease 4, Autosomal Dominant Lewy Body 44Urinary Bladder Neoplasms 42Esophageal Squamous Cell Carcinoma 41Lymphoma 39Melanoma 35Carcinoma, Squamous Cell 33Lymphoma, Non-Hodgkin 31

Interventions

Paclitaxel 2Carboplatin 2selinexor 1pazopanib 1Watchful Waiting 1Transurethral Resection of Prostate 1Pregnancy Tests 1Naproxen 1Human Papillomavirus DNA Tests 1GX-188 vaccine 1Filgrastim 1Educational Status 1Drug Therapy 1Colposcopy 1Biopsy 1Anesthesia, General 1Acetic Acid 14-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Uterine Diseases × Carboplatin × Clear all
NCT01523678 2019-07-10

Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers

Belgian Gynaecological Oncology Group

Phase 2 Completed
108 enrolled
Gynecologic

Uterine Cervical Diseases, Uterine Cervical Neoplasms, Endocrine System Diseases, Fallopian Tube Diseases, Fallopian Tube Neoplasms, Genital Diseases, Female, Genital Neoplasms, Female, Neoplasms, Neoplasms, Glandular and Epithelial, Ovarian Diseases, Ovarian Neoplasms, Peritoneal Diseases, Peritoneal Neoplasms, Urogenital Neoplasms, Uterine Diseases, Endometrial Neoplasms

NCT00561795 2012-03-22

Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors

GlaxoSmithKline

Phase 2 Completed
12 enrolled 6 charts
Gynecologic

Carcinoma, Ovarian Epithelial, Uterine Cervical Diseases, Neoplasms, Ovarian Neoplasms, Uterine Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡